The Microbiologic Profile of Diabetic Foot Infections in Turkey - TURK-DAY
TURK-DAY
1 other identifier
observational
447
1 country
1
Brief Summary
To determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedFirst Posted
Study publicly available on registry
January 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedMarch 11, 2015
March 1, 2015
3 months
December 30, 2013
March 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
Questionnaire
6 months
Study Arms (1)
Diabetic foot infection
Patients with DM (Diabetes Mellitus) presenting with a diabetic foot infection will be enrolled in the current trial to determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
Eligibility Criteria
Patients with DM presenting with a diabetic foot infection will be enrolled in the current trial to determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
You may qualify if:
- Established diagnosis of Diabetes Mellitus
- Diabetic foot wound clinically diagnosed as infected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
GATA Haydarpasa Egitim Hastanesi
Istanbul, No State Required, 34068, Turkey (Türkiye)
Related Publications (1)
Hatipoglu M, Mutluoglu M, Turhan V, Uzun G, Lipsky BA; Turk-Day Study Group; Sevim E, Demiraslan H, Eryilmaz E, Ozuguz C, Memis A, Ay H, Arda B, Uysal S, Motor VK, Kader C, Erturk A, Coskun O, Duygu F, Guler S, Altay FA, Ogutlu A, Bolukcu S, Yildiz S, Kandemir O, Aslaner H, Polat A, Karahocagil MK, Yasar KK, Sehmen E, Kilic S, Sunbul M, Gencer S, Bozkurt F, Yanik T, Oztoprak N, Batirel A, Sozen H, Kilic I, Celik I, Ay B, Tosun S, Kadanali A, Comoglu S, Denk A, Hosoglu S, Aydin O, Elaldi N, Akalin S, Kandemir B, Akbulut A, Demirdal T, Balik R, Azak E, Sengoz G. Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. J Diabetes Complications. 2016 Jul;30(5):910-6. doi: 10.1016/j.jdiacomp.2016.02.013. Epub 2016 Feb 21.
PMID: 26965794DERIVED
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Vedat Turhan, MD
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Associate Professor
Study Record Dates
First Submitted
December 30, 2013
First Posted
January 3, 2014
Study Start
January 1, 2014
Primary Completion
April 1, 2014
Study Completion
July 1, 2014
Last Updated
March 11, 2015
Record last verified: 2015-03